Ticker
RLYBCompany Name
RALLYBIO CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Core Assets | Goodwill and Intangibles |
---|---|---|---|---|
6/30/2025 | $ 51M | $ 9.45M | $ 41.56M | $ 0 |
3/31/2025 | $ 57.98M | $ 14.78M | $ 43.2M | $ 0 |
12/31/2024 | $ 68.11M | $ 13.9M | $ 54.2M | $ 0 |
9/30/2024 | $ 79.01M | $ 25.32M | $ 53.69M | $ 0 |
6/30/2024 | $ 92.43M | $ 16.67M | $ 75.76M | $ 0 |
3/31/2024 | $ 99.36M | $ 19.3M | $ 80.06M | $ 0 |
12/31/2023 | $ 115.62M | $ 24.49M | $ 91.13M | $ 0 |
9/30/2023 | $ 133.19M | $ 19.16M | $ 114.04M | $ 0 |
6/30/2023 | $ 147.58M | $ 32.56M | $ 115.02M | $ 0 |
3/31/2023 | $ 162.32M | $ 39.52M | $ 122.8M | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for RALLYBIO CORP is calculated as follows: Assets [ $ 141.86M ] - Intangibles [ $ 0 ] - CashnEq [ $ 140.23M ]
(=) Core Assets [ $ 1.63M ]
Minimum
Mar 31, 2021
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.42K |
---|---|
min | $ 0 |
max | $ 4.42B |
average | $ 805.95M |
median | $ 292.02M |
std | $ 1.06B |